Please assess the completion status of the following clinical trial:

Trial Title: Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 1) At least 18 years old~* 2) Have had a positive culture (a type of test) for MRSA during recent hospital admission or within the 30 days prior to admission or following discharge~* 3) Able to give consent or have a primary caregiver provide consent~* 4) Able to bathe or shower or have this consistently performed by a willing caregiver~Exclusion Criteria:~* 1) Known allergies to chlorhexidine or mupirocin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MRSA Decolonization (Type: ACTIVE_COMPARATOR): Participants in this arm will be instructed to complete a decolonization regimen that will involve a 5-day application of nasal mupirocin, oral CHG rinse, and CHG body wash twice a month.
- Education Arm (Type: ACTIVE_COMPARATOR): Patients randomized to standard education will receive a binder with MRSA educational materials which will include or be based upon CDC guidance for MRSA patients at home. In addition, educational material on hygiene practices to prevent MRSA infection will be provided.

Based on this trial design, predict the completion outcome and termination type (if applicable).